| 词条 | Infectious Disease Pharmacokinetics Laboratory |
| 释义 |
}}{{Infobox Organization |name = Infectious Disease Pharmacokinetics Laboratory |image = |image_border = |size = |caption = |map = |msize = |mcaption = |motto = |formation = |type = Research/Clinical Laboratory |headquarters = University of Florida |location = {{flagicon|USA}} United States |membership = |language = |leader_title = Director |leader_name = Dr. Charles Peloquin |key_people = |num_staff = |budget = |website = Official website }} The Infectious Disease Pharmacokinetics Laboratory (IDPL) is a research facility that is affiliated with the College of Pharmacy at the University of Florida.[1] OverviewIDPL focuses on the treatments for infections that include HIV, tuberculosis, and other serious infections. This facility provides therapeutic drug monitoring (TDM) using high-performance liquid chromatography and gas chromatography. IDPL has been in existence for two decades and has developed individualized drug regimens by monitoring a patient’s blood plasma or serum for target drug concentrations and then interpreting these results and advising physicians how to adjust a drug’s dosage to achieve an optimal outcome. This interdisciplinary method allows IDPL to assess each patient’s ability to absorb, metabolize and excrete drugs, which then enables them to recommend customized drug dosages based upon these pharmacokinetic factors as well as the severity of the patient’s infection. IDPL primarily focuses on tuberculosis, but they also develop drug regimens for cancer patients with fungal infections, and people with HIV. The Infectious Disease Pharmacokinetics Laboratory also serves as a national reference center for the determination of serum concentrations for the antimycobacterial, antifungal, and anti-HIV drugs, as well as linezolid. LeadershipThe director is Dr. Charles Peloquin who has been leading this facility for over 20 years. This facility is unique in that it provides finely detailed interpretations of results as applied to adjusting the drug regimens of individual patients. Dr. Peloquin's research efforts focuses on therapeutic drug monitoring and clinical trials for patients with advanced mycobacterial diseases.[2][3][4][5] References1. ^About IDPL 2. ^IDPL at UF website 3. ^Emerging Pathogens Institute 4. ^Southeastern National Tuberculosis Center 5. ^Charles Peloquin faculty page External links
3 : University of Florida|Infectious disease organisations|Microbiology organisations |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。